Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Early identification of individuals at risk of developing Alzheimer's disease (AD) dementia is important for developing disease-modifying therapies. In this study, given multimodal AD markers and clinical diagnosis of an individual from one or more timepoints, we seek to predict the clinical diagnosis, cognition and ventricular volume of the individual for every month (indefinitely) into the futur...
INTRODUCTION: Robust and reliable attenuation correction (AC) is a prerequisite for accurate quantification of activity concentration. In combined PET/MRI, AC is challenged by the lack of bone signal in the MRI from which the AC maps has to be derived. Deep learning-based image-to-image translation networks present itself as an optimal solution for MRI-derived AC (MR-AC). High robustness and gener...
INTRODUCTION: Identifying cognitively normal individuals at high risk for progression to symptomatic Alzheimer's disease (AD) is critical for early in...
OBJECTIVE: Emerging technologies such as social robots have shown to be effective in reducing loneliness and agitation for older people with dementia....
The Alzheimer's Disease Neuroimaging (ADNI) database is an expansive undertaking by government, academia, and industry to pool resources and data on s...
OBJECTIVES: To test the effects of deploying a humanoid companion robot (Kabochan) in comparison with usual care for long-term care facilities' reside...
OBJECTIVE: The aim of this research is to identify the stage of Alzheimer's Disease (AD) patients through the use of mobility data and deep learning m...
The use of robot companion pets for people in care homes has been extensively studied. The results are largely positive and suggest that they are valu...
Alzheimer's disease (AD) is a progressive incurable neurodegenerative disease and a major health problem in aging population. We show that the combine...
Promoting health and prolonging independence in the home is a priority for older adults, caregivers, clinicians, and society at large. Rapidly develop...
Tau pathology and brain atrophy are the closest correlate of cognitive decline in Alzheimer's disease (AD). Understanding heterogeneity and longitudin...
Fronto-temporal dementia (FTD) is a common type of presenile dementia, characterized by a heterogeneous clinical presentation that includes three main...
The well-being of people with dementia (PWD) living in long-term care facilities is hindered due to disengagement and social isolation. Animal-like so...
A major obstacle to treating Alzheimer's disease (AD) is our lack of understanding of the molecular mechanisms underlying selective neuronal vulnerabi...
Loss of cognitive ability is commonly associated with dementia, a broad category of progressive brain diseases. However, major depressive disorder may...
This systematic review sought to evaluate the effectiveness of non-facilitated meaningful activities for older people with dementia in long-term care ...
Several proteins including S-nitrosoglutathione reductase (GSNOR), complement Factor D, complement 3b (C3b) and Protein Kinase R-like Endoplasmic Reti...
PURPOSE: We aimed to evaluate the performance of deep learning-based generalization of ultra-low-count amyloid PET/MRI enhancement when applied to stu...
Traditional neuroimage analysis pipelines involve computationally intensive, time-consuming optimization steps, and thus, do not scale well to large c...
Many neurological diseases and delineating pathological regions have been analyzed, and the anatomical structure of the brain researched with the aid ...